| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Combined Industry and Academia Residency Program
|
McCart, Gary M.
|
|
|
34 |
4 |
p. 1115-1119
|
article
|
| 2 |
An Industry-Wide Evaluation of Drug Information Services
|
Doyle, Rebecca I.
|
|
|
34 |
4 |
p. 1139-1148
|
article
|
| 3 |
An Interdepartmental Survey of Medical Information Services: Evaluating the Impact of an Open House
|
Byrne, Kévin S.
|
|
|
34 |
4 |
p. 1155-1162
|
article
|
| 4 |
Approval Standards for Alfa Interferon Subtypes
|
Trotta, Paul P.
|
|
|
34 |
4 |
p. 1231-1246
|
article
|
| 5 |
A Progress Report: Drug Information from 1970 to 2000
|
Curran, Charles F.
|
|
|
34 |
4 |
p. 1355-1363
|
article
|
| 6 |
Clinical Study Preparation: Sponsor Support for the Quality of Site Management
|
Cordaro, C. I.
|
|
|
34 |
4 |
p. 1303-1308
|
article
|
| 7 |
Comparative Course and Outcome of the Mutual Recognition Procedure with Two Related Progestagen-Only Contraceptive Products: Cerazette® and Implanon®
|
de Boer, Willem
|
|
|
34 |
4 |
p. 1215-1221
|
article
|
| 8 |
Cost-Effective Realization of an International Product Information Database
|
Netzer, Tilo
|
|
|
34 |
4 |
p. 1365-1372
|
article
|
| 9 |
Developing an Automated Telephone Triage System for a New Product Launch
|
Gundaker, Linda F.
|
|
|
34 |
4 |
p. 1035-1039
|
article
|
| 10 |
Drug Information in Industry Versus Academia: A Pharmacy Resident’s Perspective of a Sample Case
|
Graham, Angie S.
|
|
|
34 |
4 |
p. 1121-1127
|
article
|
| 11 |
Establishing a Medical Knowledge Extranet to Enhance Medical Communications
|
Hoffman, Kirk
|
|
|
34 |
4 |
p. 1063-1068
|
article
|
| 12 |
Establishing Global Medical Information Services: Practices and Pitfalls
|
Riggins, Jennifer L.
|
|
|
34 |
4 |
p. 1077-1080
|
article
|
| 13 |
Evaluation and Critical Appraisal of a Random Sample of Drug Information Practice In United States Academic and Industry Medical Information Centers
|
Shannon, Meghan E.
|
|
|
34 |
4 |
p. 1133-1138
|
article
|
| 14 |
Expanding Medical Communications Services to Internal Customers
|
Werner, Amy L.
|
|
|
34 |
4 |
p. 1053-1061
|
article
|
| 15 |
From “Too Much, Too Late” to “Right First Time”: Quality Guru Deming’s Advice for Clinical Trials
|
Lörstad, Mats H.
|
|
|
34 |
4 |
p. 1319-1328
|
article
|
| 16 |
Guest Editor’s Note: Special Series on Medical Communications
|
Depew, Charles C.
|
|
|
34 |
4 |
p. 991-993
|
article
|
| 17 |
Herbal Supplement Information and the Consumer
|
Bouldin, Alicia S.
|
|
|
34 |
4 |
p. 1339-1353
|
article
|
| 18 |
History and Evolution of Field-Based Medical Programs
|
Morgan, Donna K.
|
|
|
34 |
4 |
p. 1049-1052
|
article
|
| 19 |
Hosting an Open House for a Medical Information Department: An Effective Educational Method
|
Matthews, Patricia A.
|
|
|
34 |
4 |
p. 1149-1154
|
article
|
| 20 |
Industry-Based Medical Information in Europe: Practices and Customer Expectations
|
Robson, Andrew S.
|
|
|
34 |
4 |
p. 1089-1095
|
article
|
| 21 |
Industry-Based Medical Information in Japan: Practices and Customer Expectations
|
Taniuchi, Noriko
|
|
|
34 |
4 |
p. 1097-1103
|
article
|
| 22 |
Insourcing International Clinical Trials to Affiliates: A Business-Driven and Medically Sound Strategy
|
Chaikin, Philip
|
|
|
34 |
4 |
p. 1293-1301
|
article
|
| 23 |
Letter to the Editor
|
Verbeke, Geert
|
|
|
34 |
4 |
p. 1373-1375
|
article
|
| 24 |
Medical Center Clinical Rotation for Pharmaceutical Drug Information Professionals
|
Pollock, Martin L.
|
|
|
34 |
4 |
p. 1129-1132
|
article
|
| 25 |
Medical-Legal Considerations Regarding the Provision of Medication-Related Information to Consumers by a Pharmaceutical Manufacturer
|
Kline, Sandy
|
|
|
34 |
4 |
p. 1017-1020
|
article
|
| 26 |
Merger Mania: Impact on the Medical Information Department
|
Culley, Colleen M.
|
|
|
34 |
4 |
p. 1163-1168
|
article
|
| 27 |
New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms
|
DiMasi, Joseph A.
|
|
|
34 |
4 |
p. 1169-1194
|
article
|
| 28 |
Outsourcing Industry Medical Information Services
|
Firth, Neelima
|
|
|
34 |
4 |
p. 1105-1113
|
article
|
| 29 |
Pharmaceutical Industry-Based Medical Information in Canada
|
Hough, Lawrence
|
|
|
34 |
4 |
p. 1081-1087
|
article
|
| 30 |
Pharmaceutical Industry Medical Communications Departments: Regulatory and Legal Perils and Pitfalls
|
Salter, Fred J.
|
|
|
34 |
4 |
p. 1009-1015
|
article
|
| 31 |
Pharmacist Employment and Satisfaction Trends at Eli Lilly and Company
|
Riggins, Jennifer L.
|
|
|
34 |
4 |
p. 1223-1229
|
article
|
| 32 |
Preparing for a Product Launch in a Medical Communications Department
|
Werner, Amy L.
|
|
|
34 |
4 |
p. 1021-1033
|
article
|
| 33 |
Preventing Adverse Drug Events (ADEs): The Role of Computer Information Systems
|
Yan, Qing
|
|
|
34 |
4 |
p. 1247-1260
|
article
|
| 34 |
Pricing and Reimbursement of Pharmaceutical Products in France
|
Friedeberg-Steward, Beatrix
|
|
|
34 |
4 |
p. 1201-1205
|
article
|
| 35 |
Reading Level of Drug Information Printouts: A Barrier to Effective Communication of Patient Medication Information
|
Rolland, Philip D.
|
|
|
34 |
4 |
p. 1329-1338
|
article
|
| 36 |
Some Commentary on Maximizing the Statistician’s Value to the Pharmaceutical Industry
|
Donahue, Rafe M. J.
|
|
|
34 |
4 |
p. 1261-1264
|
article
|
| 37 |
Statistical Approaches to Accepting Foreign Clinical Data
|
Kawai, Norisuke
|
|
|
34 |
4 |
p. 1265-1272
|
article
|
| 38 |
Strategies for Increasing Drug Inquiry Response Efficiency
|
Curran, Charles F.
|
|
|
34 |
4 |
p. 1041-1047
|
article
|
| 39 |
The Applied Therapeutics Team: An Innovative Model of Drug Information in the Pharmaceutical Industry
|
Malecha, Susan E.
|
|
|
34 |
4 |
p. 1069-1075
|
article
|
| 40 |
The Core Curriculum for Medical Communications Professionals Practicing in the Pharmaceutical Industry
|
Graves, David A.
|
|
|
34 |
4 |
p. 995-1008
|
article
|
| 41 |
The Development of Standard Economic Datasets for use in the Economic Evaluation of Medicines
|
Backhouse, Martin E.
|
|
|
34 |
4 |
p. 1273-1291
|
article
|
| 42 |
The Informed Consent Form: Document Development and Evaluation
|
Hochhauser, Mark
|
|
|
34 |
4 |
p. 1309-1317
|
article
|
| 43 |
The Role of the Food and Drug Administration in Pharmacoeconomic Evaluation During the Drug Development Process
|
Kim, Jennifer
|
|
|
34 |
4 |
p. 1207-1213
|
article
|
| 44 |
Use of Generic Drugs and Effects of the Reference Price System in Sweden
|
Nilsson, J. Lars G.
|
|
|
34 |
4 |
p. 1195-1200
|
article
|
Journal description